HomeAI · summaries
Storia in 2 fonti
SGLT2 inhibitors linked to greater risk for major diabetic foot complications vs. GLP-1s
CHICAGO — Major diabetic foot complications were more common in patients with type 2 diabetes treated with SGLT2 inhibitors than those treated with GLP-1 receptor agonists, researchers reported at ENDO 2026.However, new-onset diabetic peripheral neuropathy was lower in patients taking SGLT2 inhibitors compared with those taking GLP-1s, according to the researchers.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
GLP-1s linked to elevated rates of hypotensive events
CHICAGO — In patients being treated for hypertension, those taking a GLP-1 receptor agonist had higher rates of hypotensive events compared with those not taking one, researchers…
- ·
medpagetoday.com
GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication
Real-world data found patients on GLP-1s had lower odds of osteomyelitis, ulcers, and amputation
